Analysis of Factors Influencing Relapse and Pregnancy in Patients with Borderline Ovarian Tumors
- PMID: 34335944
- PMCID: PMC8317534
- DOI: 10.7150/jca.56387
Analysis of Factors Influencing Relapse and Pregnancy in Patients with Borderline Ovarian Tumors
Abstract
Objective: This retrospective study analyzed the factors affecting recurrence in patients after surgery with borderline ovarian tumors and postoperative recurrence and pregnancy after fertility-sparing surgery (FSS), to provide guidance for clinical treatment of borderline ovarian tumors and propose a therapeutic strategy for fertility protection. Methods: A total of 415 patients with borderline ovarian tumors were initially operated on in the gynecology ward of Shengjing Hospital Affiliated with China Medical University from September 1, 2013, to September 1, 2019. Central pathology review and prospective follow-up were carried out. The clinical and pathological data were consulted through the medical record query system of our hospital. The recurrence and pregnancy of the patients were investigated through telephone follow-up and outpatient and inpatient medical records. The influence of clinical and pathological variables on recurrence and pregnancy were evaluated using univariate/multivariate analyses. Results: In this study, 415 patients were collected, of which 21 lost follow-up, and a total of 394 eligible patients were included in the analysis. Among these patients, 25 patients relapsed with a recurrence rate of 6.3% and there were 196 patients with fertility-sparing surgery, of the 63 patients attempting to conceive, 35 were able to attain pregnancy with a pregnancy rate of 55.6%. All patients survived until the follow-up deadline. In univariate and multivariate analyses, FSS, FIGO stage, and micropapillary pattern were independent risk factors for recurrence of BOTs. FIGO stage, micropapillary pattern were independent risk factors for recurrence of BOTs with FSS. The risk of recurrence was not related to omentectomy nor postoperative chemotherapy. While omentectomy and chemotherapy had an impact on the pregnancy rate (P <0.05) and the pregnancy rate of patients without omentectomy or chemotherapy was higher. Conclusion: Omentectomy did not affect recurrence and it is not recommended as a routine operation. Adjuvant chemotherapy does not reduce the recurrence rate. While omentectomy and chemotherapy had an impact on the pregnancy rate, and both of them should be carried out more carefully in patients with fertility requirements.
Keywords: borderline ovarian tumor; fertility preservation; pregnancy; recurrence.
© The author(s).
Conflict of interest statement
Competing Interests: The authors have declared that no competing interest exists.
Similar articles
-
The impact of clinicopathologic and surgical factors on relapse and pregnancy in young patients (≤40 years old) with borderline ovarian tumors.BMC Cancer. 2018 Nov 21;18(1):1147. doi: 10.1186/s12885-018-4932-2. BMC Cancer. 2018. PMID: 30463533 Free PMC article.
-
Second fertility-sparing surgery and fertility-outcomes in patients with recurrent borderline ovarian tumors.Arch Gynecol Obstet. 2022 Oct;306(4):1177-1183. doi: 10.1007/s00404-022-06431-5. Epub 2022 Mar 23. Arch Gynecol Obstet. 2022. PMID: 35396974 Free PMC article.
-
Fertility-sparing surgery for young patients with borderline ovarian tumors (BOTs): single institution experience.J Ovarian Res. 2016 Mar 18;9:16. doi: 10.1186/s13048-016-0226-y. J Ovarian Res. 2016. PMID: 26988551 Free PMC article.
-
The feasibility of fertility-sparing surgery in treating advanced-stage borderline ovarian tumors: A meta-analysis.Taiwan J Obstet Gynecol. 2016 Jun;55(3):319-25. doi: 10.1016/j.tjog.2016.04.005. Taiwan J Obstet Gynecol. 2016. PMID: 27343308 Review.
-
Controversies in borderline ovarian tumors.J Gynecol Oncol. 2015 Oct;26(4):343-9. doi: 10.3802/jgo.2015.26.4.343. Epub 2015 Sep 23. J Gynecol Oncol. 2015. PMID: 26404125 Free PMC article. Review.
Cited by
-
Fertility-sparing surgery versus radical surgery for micropapillary serous borderline ovarian tumours: a systematic review protocol.BMJ Open. 2024 Nov 12;14(11):e077503. doi: 10.1136/bmjopen-2023-077503. BMJ Open. 2024. PMID: 39532361 Free PMC article.
-
Correlation analysis of recurrent factors in borderline ovarian tumors undergoing fertility preservation surgery.Front Oncol. 2025 Jan 22;15:1488247. doi: 10.3389/fonc.2025.1488247. eCollection 2025. Front Oncol. 2025. PMID: 39911631 Free PMC article.
-
Risk Factors for Recurrence in Serous Borderline Ovarian Tumors and Early-Stage Low-Grade Serous Ovarian Carcinoma.Curr Oncol. 2025 Apr 30;32(5):263. doi: 10.3390/curroncol32050263. Curr Oncol. 2025. PMID: 40422522 Free PMC article.
-
The challenging management of borderline ovarian tumors (BOTs) in women of childbearing age.Front Surg. 2022 Aug 23;9:973034. doi: 10.3389/fsurg.2022.973034. eCollection 2022. Front Surg. 2022. PMID: 36081590 Free PMC article. Review.
-
Predictive features of borderline ovarian tumor recurrence in patients with childbearing potential undergoing conservative treatment.Mol Clin Oncol. 2022 Jun 7;17(1):121. doi: 10.3892/mco.2022.2554. eCollection 2022 Jul. Mol Clin Oncol. 2022. PMID: 35761896 Free PMC article.
References
-
- Ludovisi M, Foo X, Mainenti S, Testa AC, Arora R, Jurkovic D. Ultrasound diagnosis of serous surface papillary borderline ovarian tumor: A case series with a review of the literature. JCU. 2015;43:573–7. - PubMed
-
- Tropé CG, Kaern J, Davidson B. Borderline ovarian tumours. Best Pract Res Clin Obstet Gynaecol. 2012;26:325–36. - PubMed
-
- Sherman ME, Mink PJ, Curtis R. et al. Survival among women with borderline ovarian tumors and ovarian carcinoma: a population-based analysis. Cancer. 2004;100:1045–52. - PubMed
-
- Leake JF, Rader JS, Woodruff JD, Rosenshein NB. Retroperitoneal lymphatic involvement with epithelial ovarian tumors of low malignant potential. Gynecol Oncol. 1991;42:124–30. - PubMed
-
- Skírnisdóttir I, Garmo H, Wilander E, Holmberg L. Borderline ovarian tumors in Sweden 1960-2005: trends in incidence and age at diagnosis compared to ovarian cancer. Int J Cancer. 2008;123:1897–901. - PubMed
LinkOut - more resources
Full Text Sources